Close X
Friday, September 20, 2024
ADVT 
National

Canada's employment continues upward trend in March

Darpan News Desk IANS, 06 Apr, 2023 03:40 PM
  • Canada's employment continues upward trend in March

Canada's employment grew by 35,000, or 0.2 per cent, in March, following little change in February and strong growth in January and December, Statistics Canada said.

Employment has generally trended up since September 2022. Over that period, the number of people employed has increased by 383,000, or 1.9 per cent, the national statistical agency added on Thursday.

Employment gains in March were concentrated among private sector employees and there was little change in the number of public sector employees and self-employed workers, the agency said.

According to the agency, for the fourth consecutive month, the unemployment rate was five per cent in March, just above the record low of 4.9 per cent observed in June and July of 2022, Xinhua news agency reported.

Total hours worked rose 0.4 per cent in March and were up 1.6 per cent on a year-over-year basis, the agency said.

Average hourly wages rose 5.3 per cent to 33.12 Canadian dollars ($24.5) on a year-over-year basis in March, compared with 5.4 per cent in February, Statistics Canada added.

MORE National ARTICLES

49 year old man dead after crash takes place in Cloverdale area of Surrey

49 year old man dead after crash takes place in Cloverdale area of Surrey
Two motorcycles were travelling east bound on Fraser Highway approaching 182 street, when they both lost control and struck the center median. The 49 year old male rider of one of the motorcycles was transported to a local area hospital where he was pronounced deceased. The other rider, a male, suffered serious injuries.

49 year old man dead after crash takes place in Cloverdale area of Surrey

Drilling down on cost of federal dental care

Drilling down on cost of federal dental care
In its 2023 budget Tuesday, the government revealed the federally administered insurance program will be far more expensive over the next five years than it originally thought. It is also projecting that ongoing costs after that will more than double to $4.4 billion per year, up from $1.7 billion.

Drilling down on cost of federal dental care

Humboldt reflects five years after bus crash

Humboldt reflects five years after bus crash
The CEO of the Horizon School Division, whose term at the helm of the hockey team has ended, was unexpectedly thrust into an international spotlight after the crash. So was his community and team. Now, Garinger says, the intense focus has faded but the small Saskatchewan city east of Saskatoon is still figuring out how to exist within that legacy.

Humboldt reflects five years after bus crash

Rogers-Shaw deal gains final approval from Ottawa

Rogers-Shaw deal gains final approval from Ottawa
The largest telecommunications deal in Canadian history will go forward after Rogers Communications Inc.'s $26-billion takeover of Shaw Communications Inc. received approval from Ottawa on Friday. The green light means the deal has cleared its final regulatory hurdle just over two years after it was first announced.

Rogers-Shaw deal gains final approval from Ottawa

Liberals' online-streaming bill closer to passing

Liberals' online-streaming bill closer to passing
Canadian Heritage Minister Pablo Rodriguez has said his government is against the amendment because it could create a loophole for big companies to avoid following the law. The U.S. government has also raised concerns that the law could discriminate against American companies, with some U.S. senators calling for a trade crackdown.

Liberals' online-streaming bill closer to passing

Ozempic puts cross-border drug sales in spotlight

Ozempic puts cross-border drug sales in spotlight
B.C. Health Minister Adrian Dix said on Tuesday he wants a federal clampdown on sales to non-residents after it was discovered that Americans were being sent thousands of doses of Ozempic in the mail from B.C., the majority prescribed by a single practitioner in Nova Scotia.    

Ozempic puts cross-border drug sales in spotlight